Inflammatory genomics

Environmental Health Perspectives

Volumn 113, Issue 12, 2005, Pages

  Gant, Timothy W ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CHEMOTACTIC PEPTIDE; GENE PRODUCT; GLUTATHIONE TRANSFERASE M1; INTERLEUKIN 6; ORNITHINE OXOACID AMINOTRANSFERASE; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

EDITORIAL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC DATABASE; GENOMICS; HISTOPATHOLOGY; INFLAMMATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXICOGENETICS;

EID: 29144466781     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.113-a794     Document Type: Editorial

References (18)

1. Albertini S. 2005. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit? Mut Res 575:102-115.
2. Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, et al. 2005. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37:1234-1241.
3. Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, et al. 2005. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am J Pathol 166:1041-1053.
4. European Bioinformatics Institute. 2005. ArrayExpress. Available: http://www.ebi.ac.uk/arrayexpress/ [accessed 7 November 2005].
5. Gant TW. 2003. Application of toxicogenomics in drug development. Drug News Perspect 16:217-221.
6. Gant TW, Baus PR, Clothier B, Riley J, Davies R, Judah DJ, et al. 2003. Gene expression profiles associated with inflammation, fibrosis, and cholestasis in mouse liver after Griseofulvin. Environ Health Perspect 111:847-853.
7. GEO. 2005. Gene Expression Omnibus. Available: http://www.ncbi.nlm.nih.gov/geo/ [accessed 7 November 2005].
8. GO. 2005. GeneOntology, Biological Process. Available: http://www.geneontology.org/ontology/process.ontology [accessed 7 November 2005].
9. Heller R, Schena M, Chai A, Shalon D, Bedilion T, Glilmore J, et al. 1997. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94:2150-2155.
10. Huang Q, Jin X, Gaillard ET, Knight BL, Pack FD, Stoltz JH, et al. 2004. Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. Mutat Res 549:147-168.
11. Jiang Y, Kang YJ, Liu J, Waalkes M. 2004. Changes in the gene expression associated with carbon tetrachloride-induced liver fibrosis persist after cessation of dosing in mice. Toxicol Sci 79:404-410.
12. Lakhani S, Ashworth A. 2001. Microarray and histopathological analysis of tumours: the future and the past? Nat Rev 1:151-157.
13. Moggs J. 2005. Molecular responses to xenoestorgens: mechanistic insights from toxicogenomics. Toxicology 213:177-193.
14. Moggs J, Tinwell H, Spurway T, Chang HS, Pate I, Lim F, et al. 2004. Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Perspect 112:1589-1606.
15. Paules R. Phenotypic anchoring:linking cause and effect. 2003. Environ Health Perspect 111:A338-A339.
16. Schmidt CW. Critical care: applying genomics to inflammation outcomes. Environ Health Perspect 113:A816-A821.
17. Waters MD, Fostel JM. 2004. Toxicogenomics and systems toxicology: aims and prospects. Nat Rev Genet 5:936-948.
18. Younossi Z, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born T, et al. 2005. A genomic and proteomic study of the spectrum nonalcoholic fatty liver disease. Hepatology 42:665-674.